Request for Covid-19 Impact Assessment of this Report
Geographically, the global Biosimilars market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Biosimilars market in North America.
Significant participants active in the global Biosimilars market include: Amgen Inc, Teva Pharmaceutical Industries Ltd., Mylan N.V, Sandoz International GmbH, Dr. Reddy’s Laboratories Ltd., Samsung Bioepis, Biocon, F. Hoffmann-La Roche AG, Pfizer Inc....
Global Biosimilars Market Segmentation:
Biosimilars market, by Biosimilars type:
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
…
Biosimilars market, by Application:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
…
Biosimilars Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Biosimilars by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Biosimilars Market-Segmentation
4.1 By Type
4.1.1 Human Growth Hormone
4.1.2 Erythropoietin
4.1.3 Monoclonal Antibodies
4.1.4 Insulin
4.1.5 Interferon
4.1.6 Granulocyte-Colony Stimulating Factor
4.1.7 Others
4.2 By End-User/Application Industry
4.2.1 Oncology
4.2.2 Blood Disorders
4.2.3 Growth Hormonal Deficiency
4.2.4 Chronic and Autoimmune Disorders
4.2.5 Others
4.3 By Geography
4.3.1 North America Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Biosimilars Production from 2014-2020
4.3.1.2 North America Biosimilars Consumption from 2014-2020
4.3.1.3 North America Biosimilars Import and Export from 2014-2020
4.3.1.4 North America Biosimilars Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Biosimilars Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Biosimilars Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Biosimilars Production from 2014-2020
4.3.2.2 Europe Biosimilars Consumption from 2014-2020
4.3.2.3 Europe Biosimilars Import and Export from 2014-2020
4.3.2.4 Europe Biosimilars Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Biosimilars Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Biosimilars Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Biosimilars Production from 2014-2020
4.3.3.2 Asia-Pacific Biosimilars Consumption from 2014-2020
4.3.3.3 Asia-Pacific Biosimilars Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Biosimilars Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Biosimilars Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Biosimilars Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Biosimilars Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Biosimilars Production from 2014-2020
4.3.4.2 Latin America Biosimilars Consumption from 2014-2020
4.3.4.3 Latin America Biosimilars Import and Export from 2014-2020
4.3.4.4 Latin America Biosimilars Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Biosimilars Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Biosimilars Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Biosimilars Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Biosimilars Production from 2014-2020
4.3.5.2 Middle East & Africa Biosimilars Consumption from 2014-2020
4.3.5.3 Middle East & Africa Biosimilars Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Biosimilars Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Biosimilars Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Biosimilars Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Biosimilars Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 Amgen Inc
5.1.1 Amgen Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Amgen Inc Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Teva Pharmaceutical Industries Ltd.
5.2.1 Teva Pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Teva Pharmaceutical Industries Ltd. Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Mylan N.V
5.3.1 Mylan N.V Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Mylan N.V Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Sandoz International GmbH
5.4.1 Sandoz International GmbH Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Sandoz International GmbH Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Dr. Reddy’s Laboratories Ltd.
5.5.1 Dr. Reddy’s Laboratories Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Dr. Reddy’s Laboratories Ltd. Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Samsung Bioepis
5.6.1 Samsung Bioepis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Samsung Bioepis Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Biocon
5.7.1 Biocon Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Biocon Sales, Growth Rate and Global Market Share from 2014-2020
5.8 F. Hoffmann-La Roche AG
5.8.1 F. Hoffmann-La Roche AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 F. Hoffmann-La Roche AG Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Pfizer Inc.
5.9.1 Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global Biosimilars Market from 2021-2026
7.1 Future Forecast of Global Biosimilars Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global Biosimilars Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global Biosimilars Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global Biosimilars Market Value ($) and Growth Rate of Biosimilars from 2014-2026
Global Biosimilars Production and Growth Rate Segment by Product Types from 2014-2026F
Global Biosimilars Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Biosimilars Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Biosimilars Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Human Growth Hormone of Biosimilars
Figure Erythropoietin of Biosimilars
Figure Monoclonal Antibodies of Biosimilars
Figure Insulin of Biosimilars
Figure Interferon of Biosimilars
Figure Granulocyte-Colony Stimulating Factor of Biosimilars
Figure Others of Biosimilars
Table Global Biosimilars Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Biosimilars Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Oncology of Biosimilars
Figure Blood Disorders of Biosimilars
Figure Growth Hormonal Deficiency of Biosimilars
Figure Chronic and Autoimmune Disorders of Biosimilars
Figure Others of Biosimilars
Table Global Biosimilars Production Value ($) by Regions
Table Global Biosimilars Production Value Share by Regions
Table Global Biosimilars Production by Regions
Table Global Biosimilars Production Share by Regions
Table Global Biosimilars Consumption by Regions
Table Global Biosimilars Consumption Share by Regions
Figure North America Biosimilars Production and Growth Rate from 2014-2020
Figure North America Biosimilars Consumption and Growth Rate from 2014-2020
Table North America Biosimilars Import and Export from 2014-2020
Table North America Biosimilars Value ($) and Growth (%) by Type from 2019-2020
Table North America Biosimilars Value ($) and Growth (%) by Application from 2019-2020
Table North America Biosimilars Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Biosimilars Participants Value ($) and Market Share (%) in 2019
Figure Europe Biosimilars Production and Growth Rate from 2014-2020
Figure Europe Biosimilars Consumption and Growth Rate from 2014-2020
Table Europe Biosimilars Import and Export from 2014-2020
Table Europe Biosimilars Value ($) and Growth (%) by Type from 2019-2020
Table Europe Biosimilars Value ($) and Growth (%) by Application from 2019-2020
Table Europe Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Biosimilars Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific Biosimilars Production and Growth Rate from 2014-2020
Figure Asia-Pacific Biosimilars Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Biosimilars Import and Export from 2014-2020
Table Asia-Pacific Biosimilars Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Biosimilars Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Biosimilars Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Biosimilars Participants Value ($) and Market Share (%) in 2019
Figure Latin America Biosimilars Production and Growth Rate from 2014-2020
Figure Latin America Biosimilars Consumption and Growth Rate from 2014-2020
Table Latin America Biosimilars Import and Export from 2014-2020
Table Latin America Biosimilars Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Biosimilars Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Biosimilars Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Biosimilars Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa Biosimilars Production and Growth Rate from 2014-2020
Figure Middle East & Africa Biosimilars Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Biosimilars Import and Export from 2014-2020
Table Middle East & Africa Biosimilars Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Biosimilars Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Biosimilars Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Biosimilars Participants Value ($) and Market Share (%) in 2019
Table Amgen Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Amgen Inc Sales and Growth Rate from 2014-2020
Figure Amgen Inc Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Teva Pharmaceutical Industries Ltd. Sales and Growth Rate from 2014-2020
Figure Teva Pharmaceutical Industries Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Mylan N.V Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Mylan N.V Sales and Growth Rate from 2014-2020
Figure Mylan N.V Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Sandoz International GmbH Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Sandoz International GmbH Sales and Growth Rate from 2014-2020
Figure Sandoz International GmbH Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Dr. Reddy’s Laboratories Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Dr. Reddy’s Laboratories Ltd. Sales and Growth Rate from 2014-2020
Figure Dr. Reddy’s Laboratories Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Samsung Bioepis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Samsung Bioepis Sales and Growth Rate from 2014-2020
Figure Samsung Bioepis Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Biocon Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Biocon Sales and Growth Rate from 2014-2020
Figure Biocon Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table F. Hoffmann-La Roche AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure F. Hoffmann-La Roche AG Sales and Growth Rate from 2014-2020
Figure F. Hoffmann-La Roche AG Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Pfizer Inc. Sales and Growth Rate from 2014-2020
Figure Pfizer Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Biosimilars Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global Biosimilars Production and Growth Rate Forecast by Regions (2021-2026)
Table Global Biosimilars Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global Biosimilars Production and Growth Rate Forecast by Types (2021-2026)
Table Global Biosimilars Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...